The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Manyak David M since year 2005.
The trader's CIK number is 1342137.
At the time of this reporting, Manyak David M is the Exec VP, Drug Discovery Svcs of Caliper Life Sciences Inc .
(stock ticker symbol CALP).
See this page for all insider trading activities at Caliper Life Sciences Inc .
Stock purchases, sales, and option exercises reported by insider Manyak David M since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-03-14
CALP
Caliper Life Sciences Inc
Sale
4,700
4.11
19,337
2007-12-20
CALP
Caliper Life Sciences Inc
Sale
1,720
5.50
9,460
2007-12-17
CALP
Caliper Life Sciences Inc
Sale
6,500
5.63
36,625
2007-12-19
CALP
Caliper Life Sciences Inc
Sale
780
5.53
4,310
2007-12-10
CALP
Caliper Life Sciences Inc
Sale
9,000
5.81
52,280
2007-12-03
CALP
Caliper Life Sciences Inc
Sale
17,849
5.52
98,615
2007-11-30
CALP
Caliper Life Sciences Inc
Sale
18,151
5.59
101,418
2007-11-05
CALP
Caliper Life Sciences Inc
Sale
9,000
5.72
51,492
2007-10-29
CALP
Caliper Life Sciences Inc
Sale
9,000
5.88
52,944
2007-10-22
CALP
Caliper Life Sciences Inc
Sale
9,000
5.80
52,238
2007-10-15
CALP
Caliper Life Sciences Inc
Sale
9,000
6.02
54,135
2007-09-14
CALP
Caliper Life Sciences Inc
Sale
2,000
5.42
10,840
2007-09-07
CALP
Caliper Life Sciences Inc
Sale
1,680
5.65
9,492
2006-11-28
CALP
Caliper Life Sciences Inc
Sale
41,118
5.52
227,176
2006-11-30
CALP
Caliper Life Sciences Inc
Sale
8,882
5.53
49,117
2006-03-14
CALP
Caliper Life Sciences Inc
Sale
50,000
6.57
328,500
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Manyak David M
(Exec VP, Drug Discovery Svcs of Caliper Life Sciences Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.